Search
My library
ORKG
NFDI
English
Sign in
We use cookies to provide a better user experience.
Data Protection
Accept
About ORKG Ask
Report issue
Statistics
Contact
Terms of use
Data protection
Imprint
Accessibility
License
System status
Improve translations
Additional file 4: Figure S2. of Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplification
Jieyi Wang (563521)
Liliane Goetsch (3446309)
Lora Tucker (3446291)
Qian Zhang (49333)
Alexandra Gonzalez (3446300)
Kedar Vaidya (3446318)
Anatol Oleksijew (1738765)
Erwin Boghaert (3446315)
Minghao Song (3446303)
Irina Sokolova (3446297)
Ekaterina Pestova (3446306)
Mark Anderson (122462)
William Pappano (3446312)
Peter Ansell (474546)
Anahita Bhathena (3446285)
Louie Naumovski (3446288)
Nathalie Corvaia (174603)
Edward Reilly (3446294)
Open link
Bookmark
Cite
Share
View in ORKG
Abstract
Extracted data
Abstract
IHC analysis of SNU5 tumors treated with ABT-700 in dose response for 21. (PPT 1098 kb
Publication date
February 2016
DOI
10.6084/m9.figshare.c.3607463_d1.v1
Language
English
Additional file 4: Figure S2. of Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplification | ORKG Ask
Related items
Additional file 5: Figure S4. of Testis specific Y-like 5: gene expression, methylation and implications for drug sensitivity in prostate carcinoma
Senthil Kumar (111785)
Jeffrey Bryan (3794914)
Magda Esebua (3794920)
James Amos-Landgraf (263993)
Tanner May (3794917)
February 2017
The expression of survivin, HIF-1α, TGF-β1 and TFE3 in mucoepidermoid carcinoma (MEC).
Yu-Fan Wang (671665)
Si-Rui Ma (502907)
Wei-Ming Wang (502909)
Cong-Fa Huang (502906)
Zhi-Li Zhao (502908)
Bing Liu (70818)
Wen-Feng Zhang (502911)
Yi-Fang Zhao (112182)
Lu Zhang (50563)
Zhi-Jun Sun (467107)
December 2014
TS2/16 attenuates tumor growth by indirectly increasing apoptosis.
Laila Ritsma (3966308)
Ipsita Dey-Guha (3966314)
Nilesh Talele (587104)
Xavier Sole (3966302)
Salony (3966305)
Joeeta Chowdhury (3966311)
Kenneth N. Ross (253523)
Sridhar Ramaswamy (173230)
April 2017
Ki67 staining of tumor samples reveals proliferation at the invasive margin.
Jong W. Yu (737678)
Sabyasachi Bhattacharya (5924957)
Niranjan Yanamandra (5924960)
David Kilian (5924963)
Hong Shi (177669)
Sapna Yadavilli (5924966)
Yuliya Katlinskaya (5924969)
Heather Kaczynski (5924972)
Michael Conner (1326543)
William Benson (5924975)
Ashleigh Hahn (5924978)
Laura Seestaller-Wehr (2401090)
Meixia Bi (5924981)
Nicholas J. Vitali (5924984)
Lyuben Tsvetkov (5924987)
Wendy Halsey (5924990)
Ashley Hughes (5319569)
Christopher Traini (5924993)
Hui Zhou (13228)
Junping Jing (5924996)
Tae Lee (42532)
David J. Figueroa (590499)
Sara Brett (5924999)
Christopher B. Hopson (5925002)
James F. Smothers (5925005)
Axel Hoos (5925008)
Roopa Srinivasan (5925011)
November 2018
CD3<sup>+</sup> cells are confined predominantly to the invasive margin in untreated tumors.
Jong W. Yu (737678)
Sabyasachi Bhattacharya (5924957)
Niranjan Yanamandra (5924960)
David Kilian (5924963)
Hong Shi (177669)
Sapna Yadavilli (5924966)
Yuliya Katlinskaya (5924969)
Heather Kaczynski (5924972)
Michael Conner (1326543)
William Benson (5924975)
Ashleigh Hahn (5924978)
Laura Seestaller-Wehr (2401090)
Meixia Bi (5924981)
Nicholas J. Vitali (5924984)
Lyuben Tsvetkov (5924987)
Wendy Halsey (5924990)
Ashley Hughes (5319569)
Christopher Traini (5924993)
Hui Zhou (13228)
Junping Jing (5924996)
Tae Lee (42532)
David J. Figueroa (590499)
Sara Brett (5924999)
Christopher B. Hopson (5925002)
James F. Smothers (5925005)
Axel Hoos (5925008)
Roopa Srinivasan (5925011)
November 2018
Immunohistochemical (IHC) analysis of orthotopic lung tumor sections.
Chandraiah Godugu (101721)
Apurva R. Patel (101724)
Ravi Doddapaneni (442684)
Jaganmohan Somagoni (532859)
Mandip Singh (101750)
March 2014
Humanized anti-STn ADCs inhibit tumor growth in a patient-derived ovarian carcinoma xenograft model.
David A. Eavarone (5566139)
Linah Al-Alem (357264)
Alexey Lugovskoy (267290)
Jillian M. Prendergast (5566142)
Rawan I. Nazer (5566145)
Jenna N. Stein (5566148)
Daniel T. Dransfield (5566151)
Jeff Behrens (5566154)
Bo R. Rueda (184239)
July 2018
Primary antibodies used in the present study.
Wen-Cheng Lu (630775)
Shou-Yen Kao (294119)
Cheng-Chieh Yang (294121)
Hsi-Feng Tu (294115)
Cheng-Hsien Wu (200213)
Kuo-Wei Chang (270431)
Shu-Chun Lin (194785)
September 2014
ARQ 092 inhibits AKT signaling in AN3CA mouse xenografts, <i>In Vivo</i>.
Yi Yu (28902)
Ronald E. Savage (813914)
Sudharshan Eathiraj (813915)
Justin Meade (813916)
Michael J. Wick (813917)
Terence Hall (813918)
Giovanni Abbadessa (486595)
Brian Schwartz (767427)
October 2015
Treatment of CRC xenografts with cetuximab-protamine siRNA controls tumor cell proliferation.
Nicole Bäumer (214974)
Jan Rehkämper (5508854)
Neele Appel (5508851)
Lisa Terheyden (5508857)
Wolfgang Hartmann (38453)
Eva Wardelmann (387825)
Frank Buchholz (166464)
Carsten Müller-Tidow (105305)
Wolfgang E. Berdel (106792)
Sebastian Bäumer (553210)
July 2018
SCCA expression correlates to a decreased overall survival and recurrence-free survival.
Joseph M. Catanzaro (353016)
Jennifer L. Guerriero (353017)
Jingxuan Liu (278357)
Erica Ullman (353019)
Namratha Sheshadri (353021)
John J. Chen (353023)
Wei-Xing Zong (353024)
February 2013
IHC analysis of T-STAR on primary invasive breast cancer where A) shows a negative case, B) a case with cytoplasmic staining and C) a case with nuclear T-STAR staining.
Sandra Sernbo (438551)
Carl A. K. Borrebaeck (438552)
Mathias Uhlén (2427553)
Karin Jirström (133199)
Sara Ek (438553)
July 2013
Additional file 2: Table S2A. of p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading
Emanuela Guerra (118189)
Alessia Cimadamore (3479537)
Pasquale Simeone (563424)
Giovanna Vacca (3479543)
Rossano Lattanzio (118191)
Gerardo Botti (68589)
Valentina Gatta (139984)
Marco DâAurora (3479540)
Barbara Simionati (3479534)
Mauro Piantelli (118205)
Saverio Alberti (118206)
August 2016
Additional file 7: of RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3
Yi Niu (456782)
Ziyou Lin (6525587)
Arabella Wan (6525590)
Honglei Chen (125181)
Heng Liang (813618)
Lei Sun (45752)
Yuan Wang (14955)
Xi Li (19208)
Xiao-feng Xiong (5467394)
Bo Wei (188204)
Xiaobin Wu (6525596)
Guohui Wan (6525599)
March 2019
CD271 expression in HPC clinical specimens and progression of HPC patients.
Takayuki Imai (22228)
Keiichi Tamai (209253)
Sayuri Oizumi (405526)
Kyoko Oyama (405527)
Kazunori Yamaguchi (151848)
Ikuro Sato (151864)
Kennichi Satoh (405528)
Kazuto Matsuura (405529)
Shigeru Saijo (405530)
Kazuo Sugamura (318678)
Nobuyuki Tanaka (336771)
April 2013
Additional file 5: Figure S4. of Testis specific Y-like 5: gene expression, methylation and implications for drug sensitivity in prostate carcinoma
Senthil Kumar (111785)
Jeffrey Bryan (3794914)
Magda Esebua (3794920)
James Amos-Landgraf (263993)
Tanner May (3794917)
February 2017
The expression of survivin, HIF-1α, TGF-β1 and TFE3 in mucoepidermoid carcinoma (MEC).
Yu-Fan Wang (671665)
Si-Rui Ma (502907)
Wei-Ming Wang (502909)
Cong-Fa Huang (502906)
Zhi-Li Zhao (502908)
Bing Liu (70818)
Wen-Feng Zhang (502911)
Yi-Fang Zhao (112182)
Lu Zhang (50563)
Zhi-Jun Sun (467107)
December 2014
TS2/16 attenuates tumor growth by indirectly increasing apoptosis.
Laila Ritsma (3966308)
Ipsita Dey-Guha (3966314)
Nilesh Talele (587104)
Xavier Sole (3966302)
Salony (3966305)
Joeeta Chowdhury (3966311)
Kenneth N. Ross (253523)
Sridhar Ramaswamy (173230)
April 2017
Ki67 staining of tumor samples reveals proliferation at the invasive margin.
Jong W. Yu (737678)
Sabyasachi Bhattacharya (5924957)
Niranjan Yanamandra (5924960)
David Kilian (5924963)
Hong Shi (177669)
Sapna Yadavilli (5924966)
Yuliya Katlinskaya (5924969)
Heather Kaczynski (5924972)
Michael Conner (1326543)
William Benson (5924975)
Ashleigh Hahn (5924978)
Laura Seestaller-Wehr (2401090)
Meixia Bi (5924981)
Nicholas J. Vitali (5924984)
Lyuben Tsvetkov (5924987)
Wendy Halsey (5924990)
Ashley Hughes (5319569)
Christopher Traini (5924993)
Hui Zhou (13228)
Junping Jing (5924996)
Tae Lee (42532)
David J. Figueroa (590499)
Sara Brett (5924999)
Christopher B. Hopson (5925002)
James F. Smothers (5925005)
Axel Hoos (5925008)
Roopa Srinivasan (5925011)
November 2018
CD3<sup>+</sup> cells are confined predominantly to the invasive margin in untreated tumors.
Jong W. Yu (737678)
Sabyasachi Bhattacharya (5924957)
Niranjan Yanamandra (5924960)
David Kilian (5924963)
Hong Shi (177669)
Sapna Yadavilli (5924966)
Yuliya Katlinskaya (5924969)
Heather Kaczynski (5924972)
Michael Conner (1326543)
William Benson (5924975)
Ashleigh Hahn (5924978)
Laura Seestaller-Wehr (2401090)
Meixia Bi (5924981)
Nicholas J. Vitali (5924984)
Lyuben Tsvetkov (5924987)
Wendy Halsey (5924990)
Ashley Hughes (5319569)
Christopher Traini (5924993)
Hui Zhou (13228)
Junping Jing (5924996)
Tae Lee (42532)
David J. Figueroa (590499)
Sara Brett (5924999)
Christopher B. Hopson (5925002)
James F. Smothers (5925005)
Axel Hoos (5925008)
Roopa Srinivasan (5925011)
November 2018
Immunohistochemical (IHC) analysis of orthotopic lung tumor sections.
Chandraiah Godugu (101721)
Apurva R. Patel (101724)
Ravi Doddapaneni (442684)
Jaganmohan Somagoni (532859)
Mandip Singh (101750)
March 2014
Humanized anti-STn ADCs inhibit tumor growth in a patient-derived ovarian carcinoma xenograft model.
David A. Eavarone (5566139)
Linah Al-Alem (357264)
Alexey Lugovskoy (267290)
Jillian M. Prendergast (5566142)
Rawan I. Nazer (5566145)
Jenna N. Stein (5566148)
Daniel T. Dransfield (5566151)
Jeff Behrens (5566154)
Bo R. Rueda (184239)
July 2018
Primary antibodies used in the present study.
Wen-Cheng Lu (630775)
Shou-Yen Kao (294119)
Cheng-Chieh Yang (294121)
Hsi-Feng Tu (294115)
Cheng-Hsien Wu (200213)
Kuo-Wei Chang (270431)
Shu-Chun Lin (194785)
September 2014
ARQ 092 inhibits AKT signaling in AN3CA mouse xenografts, <i>In Vivo</i>.
Yi Yu (28902)
Ronald E. Savage (813914)
Sudharshan Eathiraj (813915)
Justin Meade (813916)
Michael J. Wick (813917)
Terence Hall (813918)
Giovanni Abbadessa (486595)
Brian Schwartz (767427)
October 2015
Treatment of CRC xenografts with cetuximab-protamine siRNA controls tumor cell proliferation.
Nicole Bäumer (214974)
Jan Rehkämper (5508854)
Neele Appel (5508851)
Lisa Terheyden (5508857)
Wolfgang Hartmann (38453)
Eva Wardelmann (387825)
Frank Buchholz (166464)
Carsten Müller-Tidow (105305)
Wolfgang E. Berdel (106792)
Sebastian Bäumer (553210)
July 2018
SCCA expression correlates to a decreased overall survival and recurrence-free survival.
Joseph M. Catanzaro (353016)
Jennifer L. Guerriero (353017)
Jingxuan Liu (278357)
Erica Ullman (353019)
Namratha Sheshadri (353021)
John J. Chen (353023)
Wei-Xing Zong (353024)
February 2013
IHC analysis of T-STAR on primary invasive breast cancer where A) shows a negative case, B) a case with cytoplasmic staining and C) a case with nuclear T-STAR staining.
Sandra Sernbo (438551)
Carl A. K. Borrebaeck (438552)
Mathias Uhlén (2427553)
Karin Jirström (133199)
Sara Ek (438553)
July 2013
Additional file 2: Table S2A. of p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading
Emanuela Guerra (118189)
Alessia Cimadamore (3479537)
Pasquale Simeone (563424)
Giovanna Vacca (3479543)
Rossano Lattanzio (118191)
Gerardo Botti (68589)
Valentina Gatta (139984)
Marco DâAurora (3479540)
Barbara Simionati (3479534)
Mauro Piantelli (118205)
Saverio Alberti (118206)
August 2016
Additional file 7: of RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3
Yi Niu (456782)
Ziyou Lin (6525587)
Arabella Wan (6525590)
Honglei Chen (125181)
Heng Liang (813618)
Lei Sun (45752)
Yuan Wang (14955)
Xi Li (19208)
Xiao-feng Xiong (5467394)
Bo Wei (188204)
Xiaobin Wu (6525596)
Guohui Wan (6525599)
March 2019
CD271 expression in HPC clinical specimens and progression of HPC patients.
Takayuki Imai (22228)
Keiichi Tamai (209253)
Sayuri Oizumi (405526)
Kyoko Oyama (405527)
Kazunori Yamaguchi (151848)
Ikuro Sato (151864)
Kennichi Satoh (405528)
Kazuto Matsuura (405529)
Shigeru Saijo (405530)
Kazuo Sugamura (318678)
Nobuyuki Tanaka (336771)
April 2013
Additional file 5: Figure S4. of Testis specific Y-like 5: gene expression, methylation and implications for drug sensitivity in prostate carcinoma
Senthil Kumar (111785)
Jeffrey Bryan (3794914)
Magda Esebua (3794920)
James Amos-Landgraf (263993)
Tanner May (3794917)
February 2017
The expression of survivin, HIF-1α, TGF-β1 and TFE3 in mucoepidermoid carcinoma (MEC).
Yu-Fan Wang (671665)
Si-Rui Ma (502907)
Wei-Ming Wang (502909)
Cong-Fa Huang (502906)
Zhi-Li Zhao (502908)
Bing Liu (70818)
Wen-Feng Zhang (502911)
Yi-Fang Zhao (112182)
Lu Zhang (50563)
Zhi-Jun Sun (467107)
December 2014
TS2/16 attenuates tumor growth by indirectly increasing apoptosis.
Laila Ritsma (3966308)
Ipsita Dey-Guha (3966314)
Nilesh Talele (587104)
Xavier Sole (3966302)
Salony (3966305)
Joeeta Chowdhury (3966311)
Kenneth N. Ross (253523)
Sridhar Ramaswamy (173230)
April 2017
View in ORKG
DOI